176 related articles for article (PubMed ID: 23306806)
1. Correlation between [¹⁸F]FDG PET/CT and volume perfusion CT in primary tumours and mediastinal lymph nodes of non-small-cell lung cancer.
Sauter AW; Spira D; Schulze M; Pfannenberg C; Hetzel J; Reimold M; Klotz E; Claussen CD; Horger MS
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):677-84. PubMed ID: 23306806
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.
Sauter AW; Winterstein S; Spira D; Hetzel J; Schulze M; Mueller M; Pfannenberg C; Claussen CD; Klotz E; Hann von Weyhern C; Horger MS
J Nucl Med; 2012 Apr; 53(4):521-9. PubMed ID: 22414637
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic ability of
Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET parameters predicting mediastinal malignancy in lung cancer.
Serra Fortuny M; Gallego M; Berna L; Montón C; Vigil L; Masdeu MJ; Fernández-Villar A; Botana MI; Cordovilla R; García-Luján R; Cases E; Monsó E
BMC Pulm Med; 2016 Dec; 16(1):177. PubMed ID: 27931198
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
[TBL] [Abstract][Full Text] [Related]
6. [Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer].
Shao T; Yu L; Li Y; Chen M
Zhongguo Fei Ai Za Zhi; 2015 Mar; 18(3):155-60. PubMed ID: 25800571
[TBL] [Abstract][Full Text] [Related]
7. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
Liu J; Li C; Hu M; Lu J; Shi X; Xing L; Sun X; Fu Z; Yu J; Meng X
Medicine (Baltimore); 2015 May; 94(17):e678. PubMed ID: 25929896
[TBL] [Abstract][Full Text] [Related]
8. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
[TBL] [Abstract][Full Text] [Related]
9. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
Zhai X; Guo Y; Qian X
Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109
[TBL] [Abstract][Full Text] [Related]
10. Primary tumor PET/CT [¹⁸F]FDG uptake is an independent predictive factor for regional lymph node metastasis in patients with non-small cell lung cancer.
Li M; Wu N; Zheng R; Liang Y; Liu Y; Zhang W; Li N; Zhao P
Cancer Imaging; 2013 Feb; 12(3):566-72. PubMed ID: 23399986
[TBL] [Abstract][Full Text] [Related]
11. Correlation study between flash dual source CT perfusion imaging and regional lymph node metastasis of non-small cell lung cancer.
Huang T; Sun H; Luo X; Zhang X; Jin K; Wang F; Sun L; Cheng N; Wu S; Lou Q; Li B
BMC Cancer; 2020 Jun; 20(1):547. PubMed ID: 32532248
[TBL] [Abstract][Full Text] [Related]
12. Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.
Perigaud C; Bridji B; Roussel JC; Sagan C; Mugniot A; Duveau D; Baron O; Despins P
Eur J Cardiothorac Surg; 2009 Oct; 36(4):731-6. PubMed ID: 19632852
[TBL] [Abstract][Full Text] [Related]
13. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.
Kanzaki R; Higashiyama M; Fujiwara A; Tokunaga T; Maeda J; Okami J; Kozuka T; Hosoki T; Hasegawa Y; Takami M; Tomita Y; Kodama K
Lung Cancer; 2011 Mar; 71(3):333-7. PubMed ID: 20619479
[TBL] [Abstract][Full Text] [Related]
14. Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid
Yang DM; Palma D; Louie A; Malthaner R; Fortin D; Rodrigues G; Yaremko B; Laba J; Gaede S; Warner A; Inculet R; Lee TY
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):94-101. PubMed ID: 30281918
[TBL] [Abstract][Full Text] [Related]
15. Improving diagnostic performance of
Yang DD; Mirvis E; Goldring J; Patel ARC; Wagner T
Clin Radiol; 2019 Oct; 74(10):818.e17-818.e23. PubMed ID: 31420186
[TBL] [Abstract][Full Text] [Related]
16. Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography.
Takenaka T; Yano T; Morodomi Y; Ito K; Miura N; Kawano D; Shoji F; Baba S; Abe K; Honda H; Maehara Y
Surg Today; 2012 Oct; 42(10):934-9. PubMed ID: 22864936
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone Suppression FDG PET/CT for Differentiating between True- and False-Positive Pulmonary and Mediastinal Lymph Node Metastases in Non-Small Cell Lung Cancer: A Pilot Study of FDG PET/CT after Oral Administration of Dexamethasone.
Nakajo M; Nakajo M; Nakayama H; Jinguji M; Nakabeppu Y; Higashi M; Nakamura Y; Sato M; Yoshiura T
Radiology; 2016 Apr; 279(1):246-53. PubMed ID: 26579562
[TBL] [Abstract][Full Text] [Related]
18. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.
Vansteenkiste JF; Stroobants SG; De Leyn PR; Dupont PJ; Verschakelen JA; Nackaerts KL; Mortelmans LA
Chest; 1997 Dec; 112(6):1480-6. PubMed ID: 9404742
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
20. Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule.
Lee SM; Park CM; Paeng JC; Im HJ; Goo JM; Lee HJ; Kang CH; Kim YW; Kim JI
Eur Radiol; 2012 Jul; 22(7):1556-63. PubMed ID: 22358427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
